January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …

ratiotx.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …

prnewswire.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …

yahoo.com

Ratio Therapeutics Secures $50M Series B To Develop Cancer …

6 days from now

Jan 18, 2024  · Ratio Therapeutics Secures $50M Series B to Develop Cancer Treatments. ... Boston-based pharmaceutical company Ratio Therapeutics has announced the completion of …

builtinboston.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …

biospace.com

Ratio Therapeutics Secures Funds For Cancer Radiotherapies

6 days from now

Jan 18, 2024  · Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing targeted radiotherapies for cancer treatment. The funding, which …

pharmaceutical-technology.com

Ratio Therapeutics Raises $50M In Series B Financing

6 days from now

Jan 17, 2024  · Ratio Therapeutics Raises $50M in Series B Financing ... Ratio said it also plans to develop new radiopharmaceuticals using its Trillium and Macropa technology platforms. The …

precisionmedicineonline.com

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

6 days from now

On January 17, 2024 Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the …

1stoncology.com

January 17, 2024 - Ratio Therapeutics

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …

ratiotx.com

Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase

6 days from now

Jan 17, 2024  · Built In — Ratio Therapeutics Secures $50M Series B to Develop Cancer Treatments . ... January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing …

crunchbase.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, MA, USA I January 17, 2024 I Ratio …

pipelinereview.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio …

upmatters.com

Series B - Ratio Therapeutics - 2024-01-17 - Recent News

6 days from now

Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Fierce Pharma — BMS-backed radiopharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic

crunchbase.com

News - Ratio Therapeutics

6 days from now

January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. Boston-Based Radiopharmaceutical Company …

ratiotx.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, January 17, 2024-- Ratio Therapeutics Inc. (Ratio), a …

vcaonline.com

Novartis Scoops Up Ratio Therapeutics' SSTR2-Directed ...

6 days from now

2 days ago  · Novartis is paying Ratio $745 million upfront and in milestone payments to gain access to Ratio's radioligand therapy discovery and development expertise and its technology …

precisionmedicineonline.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 -- (Healthcare Sales & Marketing Network) -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop …

salesandmarketingnetwork.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Jan 17, 2024  · Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment

pipelinereview.eu

Ratio Therapeutics Closes $50M Series B Financing - Citybiz

6 days from now

Jan 17, 2024  · Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and …

citybiz.co